IBDEI0Q1 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12793,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12793,1,1,0)
 ;;=1^173.92
 ;;^UTILITY(U,$J,358.3,12793,1,2,0)
 ;;=2^SCC SKIN, SITE UNSP
 ;;^UTILITY(U,$J,358.3,12793,2)
 ;;=^340492
 ;;^UTILITY(U,$J,358.3,12794,0)
 ;;=173.99^^75^791^56
 ;;^UTILITY(U,$J,358.3,12794,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12794,1,1,0)
 ;;=1^173.99
 ;;^UTILITY(U,$J,358.3,12794,1,2,0)
 ;;=2^SKIN, MALIGNANT SITE UNSP
 ;;^UTILITY(U,$J,358.3,12794,2)
 ;;=^340493
 ;;^UTILITY(U,$J,358.3,12795,0)
 ;;=174.9^^75^791^8
 ;;^UTILITY(U,$J,358.3,12795,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12795,1,1,0)
 ;;=1^174.9
 ;;^UTILITY(U,$J,358.3,12795,1,2,0)
 ;;=2^BREAST CANCER-FEMALE
 ;;^UTILITY(U,$J,358.3,12795,2)
 ;;=^267202
 ;;^UTILITY(U,$J,358.3,12796,0)
 ;;=189.0^^75^791^50
 ;;^UTILITY(U,$J,358.3,12796,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12796,1,1,0)
 ;;=1^189.0
 ;;^UTILITY(U,$J,358.3,12796,1,2,0)
 ;;=2^RENAL CELL CANCER
 ;;^UTILITY(U,$J,358.3,12796,2)
 ;;=^73523
 ;;^UTILITY(U,$J,358.3,12797,0)
 ;;=149.0^^75^791^45
 ;;^UTILITY(U,$J,358.3,12797,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12797,1,1,0)
 ;;=1^149.0
 ;;^UTILITY(U,$J,358.3,12797,1,2,0)
 ;;=2^PHARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,12797,2)
 ;;=^267051
 ;;^UTILITY(U,$J,358.3,12798,0)
 ;;=173.00^^75^791^23
 ;;^UTILITY(U,$J,358.3,12798,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12798,1,1,0)
 ;;=1^173.00
 ;;^UTILITY(U,$J,358.3,12798,1,2,0)
 ;;=2^LIP CANCER,SKIN NOS
 ;;^UTILITY(U,$J,358.3,12798,2)
 ;;=^340596
 ;;^UTILITY(U,$J,358.3,12799,0)
 ;;=199.1^^75^791^37
 ;;^UTILITY(U,$J,358.3,12799,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12799,1,1,0)
 ;;=1^199.1
 ;;^UTILITY(U,$J,358.3,12799,1,2,0)
 ;;=2^MALIGNANT NEOPLASM NOS
 ;;^UTILITY(U,$J,358.3,12799,2)
 ;;=^87705
 ;;^UTILITY(U,$J,358.3,12800,0)
 ;;=V66.7^^75^792^1
 ;;^UTILITY(U,$J,358.3,12800,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12800,1,1,0)
 ;;=1^V66.7
 ;;^UTILITY(U,$J,358.3,12800,1,2,0)
 ;;=2^Hospice/Palliative Care-USE w/ ea encounter
 ;;^UTILITY(U,$J,358.3,12800,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,12801,0)
 ;;=348.1^^75^793^1
 ;;^UTILITY(U,$J,358.3,12801,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12801,1,1,0)
 ;;=1^348.1
 ;;^UTILITY(U,$J,358.3,12801,1,2,0)
 ;;=2^ANOXIC BRAIN DAMAGE
 ;;^UTILITY(U,$J,358.3,12801,2)
 ;;=^7979
 ;;^UTILITY(U,$J,358.3,12802,0)
 ;;=348.5^^75^793^2
 ;;^UTILITY(U,$J,358.3,12802,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12802,1,1,0)
 ;;=1^348.5
 ;;^UTILITY(U,$J,358.3,12802,1,2,0)
 ;;=2^CEREBRAL EDEMA
 ;;^UTILITY(U,$J,358.3,12802,2)
 ;;=^16710
 ;;^UTILITY(U,$J,358.3,12803,0)
 ;;=348.4^^75^793^3
 ;;^UTILITY(U,$J,358.3,12803,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12803,1,1,0)
 ;;=1^348.4
 ;;^UTILITY(U,$J,358.3,12803,1,2,0)
 ;;=2^COMPRESSION OF BRAIN
 ;;^UTILITY(U,$J,358.3,12803,2)
 ;;=^27114
 ;;^UTILITY(U,$J,358.3,12804,0)
 ;;=291.1^^75^793^7
 ;;^UTILITY(U,$J,358.3,12804,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12804,1,1,0)
 ;;=1^291.1
 ;;^UTILITY(U,$J,358.3,12804,1,2,0)
 ;;=2^DEMENTIA,ALCOHOL-INDUCED
 ;;^UTILITY(U,$J,358.3,12804,2)
 ;;=^331823
 ;;^UTILITY(U,$J,358.3,12805,0)
 ;;=331.0^^75^793^8
 ;;^UTILITY(U,$J,358.3,12805,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12805,1,1,0)
 ;;=1^331.0
 ;;^UTILITY(U,$J,358.3,12805,1,2,0)
 ;;=2^DEMENTIA,ALZHEIMER'S DISEASE
 ;;^UTILITY(U,$J,358.3,12805,2)
 ;;=^5679
 ;;^UTILITY(U,$J,358.3,12806,0)
 ;;=292.82^^75^793^9
 ;;^UTILITY(U,$J,358.3,12806,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12806,1,1,0)
 ;;=1^292.82
 ;;^UTILITY(U,$J,358.3,12806,1,2,0)
 ;;=2^DEMENTIA,DRUG-INDUCED
 ;;^UTILITY(U,$J,358.3,12806,2)
 ;;=^331832
